Business
fromwww.theguardian.com
4 days agoAstraZeneca to upgrade US listing in knock-back for London'
AstraZeneca will list shares directly on the New York Stock Exchange, replacing ADRs on Nasdaq while retaining its Cambridge headquarters and London listing.